Johnson & Johnson has reached an agreement with the US government to lower drug prices for Americans in exchange for tariff exemptions, participating in initiatives to make medicines more affordable and building new manufacturing facilities in the US as part of a broader investment plan.
Johnson & Johnson has reached an agreement with the U.S. government to lower drug prices for Americans in exchange for tariff exemptions, participating in discounted drug sales and expanding manufacturing investments in the U.S.
Countries including Japan, Australia, and Taiwan have suspended some US parcel shipments following the end of tariff exemptions under the Trump administration, causing disruptions to postal networks and e-commerce supply chains globally.